Posted on May 28th, 20195/28/19
CHICAGO – May 28, 2019 – EVERSANA,™ the leading independent provider of commercial services to the life science industry, today announced the acquisition of Alamo Pharma Services®, Inc. and BexR Logistix®, LLC Telesales from Mission Pharmacal® Company. Headquartered in Doylestown, Pa., Alamo is a leader in field sales, marketing and clinical solutions for pharmaceutical and […]
Posted on May 3rd, 20195/3/19
We are excited to be a co-sponsor of the upcoming Advanced Therapies & Regenerative Medicine Congress & Expo. The conference will be held from May 15-17 in London, UK. Scott Clark, SVP for Global Strategic Alliances, will join a panel of esteemed industry thought leaders – from Cryoport, Mesoblast and UC Davis Health – in […]
Posted on May 3rd, 20195/3/19
EVERSANA proudly announces our participation at ISPOR New Orleans as a Bronze Sponsor. ISPOR 2019, held May 18-22 in New Orleans, LA, is the leading global conference for Health Economics and Outcomes Research. This year’s conference theme: A New Era in HEOR connects the continual shift in the global healthcare landscape with essential developments in […]
Posted on April 30th, 20194/30/19
Las Vegas, Nev. — April 30, 2019 – EVERSANA™, the leading independent provider of global services to the life science industry, and OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform focused on affordability and adherence, today announced their partnership to modernize the patient experience and improve health outcomes by combining a real-time electronic […]
Posted on April 29th, 20194/29/19
Chicago, IL – April 29, 2019 – EVERSANA,™ the leading independent provider of global services to the life science industry, today announced that expansions to its cold chain storage capabilities are complete and ready to meet the growing 3PL and complex channel distribution needs of the pharmaceutical industry. The investment doubles the company’s refrigeration capabilities […]
Posted on April 22nd, 20194/22/19
Over the last several years, market demand for biosimilars has accelerated particularly for high value reference products. Efforts have been undertaken to provide education, experience sharing platforms as well as coordinating tenders across regions in the UK. Given the success of these strategies in terms of market share penetration are there really any barriers which […]
Posted on April 22nd, 20194/22/19
EVERSANA is a premier sponsor at the 21st Annual Medicaid and Government Pricing Congress on May 20-22, 2019, taking place in Orlando, Florida. Meet our team of experts who will be part of the discussion. Michael Kurland, VP, Revenue Management & Compliance Solutions Tuesday, May 21 at 4:45 pm Workshop G: Large Pharma (panelist) Joseph Birdsall, […]
Posted on April 15th, 20194/15/19
EVERSANA is a key sponsor at EYEFORPHARMA, taking place April 16-17 in Philadelphia. Join our Kristin LaBounty Phillips from The Patient Experience Project, an EVERSANA agency, on Wednesday, April 17, at 9 am in the Pink Room as she moderates a panel of esteemed industry colleagues—from Pfizer, AstraZeneca, and Patient Power LLC.— in a discussion […]
Posted on April 8th, 20194/8/19
EVERSANA is a proud gold sponsor of Asembia 2019 Specialty Pharmacy conference, taking place from April 29-May 2, 2019 in Las Vegas NV. Please join our team of experts for a conversation as we share our story on how we partner with pharmaceutical manufacturers to perform as an extension of their team and inform decisions […]
Posted on March 20th, 20193/20/19
ENSURE THE PATIENT IS AT THE CENTER OF YOUR STRATEGY EVERSANA was a proud sponsor of The Patient Congress, held this year in Philadelphia, PA. The two-day conference featured three tracks – Patient Adherence and Engagement, Patient Advocacy, and Rare Disease Market Access and Orphan Drug Commercialization – all focused on incorporating the patient voice […]
